Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The HistoSonics Edison System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY US)

NCT05820087 is registered in ClinicalTrials.gov with HistoSonics, Inc. as lead sponsor.

NCT NCT05820087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05820087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The HistoSonics Edison System for Treatment of Primary Solid Renal Tumors Using Histotripsy (#HOPE4KIDNEY US)
Lead sponsor
HistoSonics, Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 4, 2024
Completion date
July 31, 2030
Enrollment
67 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, renal cancer, tumor, tumor, benign, tumor, solid